(VIANEWS) – DANONE (BN.PA), SANOFI (SAN.PA), RAMADA (RAM.LS) are the highest payout ratio stocks on this list.
We have collected information regarding stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. DANONE (BN.PA)
135.48% Payout Ratio
Danone S.A. operates in the food and beverage industry in Europe, Ukraine, North America, China, North Asia, the Oceania, Latin America, rest of Asia, Africa, Turkey, the Middle East, and the Commonwealth of Independent States. The company operates through Essential Dairy & Plant-Based, Specialized Nutrition, and Waters segments. It produces and distributes yogurts, dairy products, coffee creamers and drinks, beverages, plant-based products, ice creams, frozen desserts, and cheese products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, Danone, Light & Fit, Oikos, YoPRO, International Delight, SToK, Silk, Follow Your Heart, and So Delicious. The company also provides specialized nutrition, including formulas and complementary feeding for babies and young children; and special medical purposes food for children and adults under the Aptamil, Nutrilon, Gallia, Cow & Gate, Bebelac, and Blédina brands. In addition, it offers tube feeding products under the Nutrison name; and oral nutritional supplements under the Fortimel and NutriDrink names. Further, the company provides mineral waters from natural sources, waters infused with natural fruit extracts, fruit juices, and vitamins under the evian, Volvic, AQUA, Mizone, Bonafont, Salus, Hayat, Sirma, Font Vella, Lanjarón, and Zywiec Zdroj brands. It distributes its products through retail chains and traditional market outlets; convenience stores; hotels, restaurants, and coffee outlets; hospitals, clinics, and pharmacies; and e-commerce channels. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, DANONE has a trailing twelve months EPS of €1.36.
PE Ratio
DANONE has a trailing twelve months price to earnings ratio of 44.04. Meaning, the purchaser of the share is investing €44.04 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.49%.
Volume
Today’s last reported volume for DANONE is 1213070 which is 17.71% above its average volume of 1030510.
More news about DANONE.
2. SANOFI (SAN.PA)
111.9% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 3.73%.
Volume
Today’s last reported volume for SANOFI is 1839940 which is 37.38% above its average volume of 1339290.
Moving Average
SANOFI’s worth is way under its 50-day moving average of €101.66 and under its 200-day moving average of €93.15.
More news about SANOFI.
3. RAMADA (RAM.LS)
83.33% Payout Ratio
Ramada Investimentos e Industria, S.A. primarily operates in the steel and wire drawing business in Portugal and internationally. The company operates through Industry and Real Estate segments. It offers steel for use in the construction of machines and components; and production of tools, including dies, cutters, and moulds for industrial markets, such as plastic mold manufacturing, automotive industry components, capital goods, and components for household appliances and electronics. The company also manufactures and sells steel wires for the industrial, agriculture, and civil construction industries. In addition, it manages and leases real estate properties comprising forestry assets; and manages financial investments. The company was formerly known as F. Ramada Investimentos, SGPS, S.A. Ramada Investimentos e Industria, S.A. was founded in 1935 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, RAMADA has a trailing twelve months EPS of €0.42.
PE Ratio
RAMADA has a trailing twelve months price to earnings ratio of 16.38. Meaning, the purchaser of the share is investing €16.38 for every euro of annual earnings.
Volume
Today’s last reported volume for RAMADA is 13899 which is 202.87% above its average volume of 4589.
Moving Average
RAMADA’s worth is above its 50-day moving average of €6.49 and higher than its 200-day moving average of €6.75.
Sales Growth
RAMADA’s sales growth is negative 18.9% for the ongoing quarter and 16% for the next.
More news about RAMADA.
4. BW LPG (BWLPG.OL)
57.66% Payout Ratio
BW LPG Limited, an investment holding company, engages in ship owning and chartering activities worldwide. The company operates through Shipping and Product Services segments. The company involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. It also offers integrated liquified petroleum gas (LPG) delivery services and support; wholesale and trade of LPG; and management services. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr39.13.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 3.98. Meaning, the purchaser of the share is investing kr3.98 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Volume
Today’s last reported volume for BW LPG is 88535 which is 72.33% below its average volume of 319969.
Yearly Top and Bottom Value
BW LPG’s stock is valued at kr155.60 at 12:10 EST, way higher than its 52-week high of kr121.70.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BW LPG’s EBITDA is 79.74.
Sales Growth
BW LPG’s sales growth is 20.3% for the current quarter and 31.1% for the next.
More news about BW LPG.
5. COVIVIO (COV.PA)
57.08% Payout Ratio
Thanks to its partnering history, its real estate expertise and its European culture, Covivio is inventing today's user experience and designing tomorrow's city. A preferred real estate player at the European level, Covivio is close to its end users, capturing their aspirations, combining work, travel, living, and co-inventing vibrant spaces. A benchmark in the European real estate market with €23.1 bn in assets, Covivio offers support to companies, hotel brands and territories in their pursuit for attractiveness, transformation and responsible performance. Build sustainable relationships and well-being, is the Covivio's Purpose who expresses its role as a responsible real estate operator to all its stakeholders: customers, shareholders and financial partners, internal teams, local authorities but also to future generations and the planet. Furthermore, its living, dynamic approach opens up exciting project and career prospects for its teams. Covivio's shares are listed in the Euronext Paris A compartment (FR0000064578 – COV), are admitted to trading on the SRD, and are included in the composition of the MSCI, SBF 120, Euronext IEIF “SIIC France” and CAC Mid100 indices, in the “EPRA” and “GPR 250” benchmark European real estate indices, and in the ESG FTSE4 Good, CAC SBT 1.5°C, DJSI World & Europe, Euronext Vigeo (World 120, Eurozone 120, Europe 120 and France 20), Euronext CDP Environment France EW, ISS ESG, Ethibel and Gaïa ethical indices and also holds the following awards and ratings: CDP (A), GRESB (90/100, 5-Star, 100% public disclosure), Vigeo-Eiris (A1+), ISS-ESG (B-) and MSCI (AAA).
Earnings Per Share
As for profitability, COVIVIO has a trailing twelve months EPS of €-14.55.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.55%.
More news about COVIVIO.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
More news about 1.
